Grant: Catalyst Grant: Pilot Projects in Aging
University of British Columbia
$50,000.00
Regultion of UCHL1 in neurodegeneation
FY 2009-10
Summary
Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is a deubiquitinating enzyme that plays a regulatory role in targeting proteins for proteosomal degradation. Reduced UCH-L1 levels have been observed in various neurodegenerative diseases, and expression of UCH-L1 can rescues memory deficits in Alzheimer's Disease model mice. However, the mechanisms regulating UCH-L1 expression have not been determined. This proposal seeks to examine the regulation of the UCHL1 gene expression and its role in neuronal death. Our study will provide insights to help us to further delineate the development of AD. Furthermore, it will open a new avenues, i.e., specifically targeting UCH-L1 signaling pathway, for developing therapeutic interventions for AD.
Department
Program
Catalyst Grant: Pilot Projects in Aging
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
189227
Name
Song Weihong
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Institute of Aging Pilot Projects
Projecttitle
Regultion of UCHL1 in neurodegeneation
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Pilot Projects in Aging
Keyworddelim
Molecular Mechanism; Neurodegeneration; Uch-L1
Abstract
Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is a deubiquitinating enzyme that plays a regulatory role in targeting proteins for proteosomal degradation. Reduced UCH-L1 levels have been observed in various neurodegenerative diseases, and expression of UCH-L1 can rescues memory deficits in Alzheimer's Disease model mice. However, the mechanisms regulating UCH-L1 expression have not been determined. This proposal seeks to examine the regulation of the UCHL1 gene expression and its role in neuronal death. Our study will provide insights to help us to further delineate the development of AD. Furthermore, it will open a new avenues, i.e., specifically targeting UCH-L1 signaling pathway, for developing therapeutic interventions for AD.
Competitiondate
200909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Song, Weihong
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $50,000~ $0~